Advertisement
Advertisement
JANX
Janux Therapeutics, Inc. Common Stock
16.66
USDSponsored
-0.40
-2.34%
Oct 23, 15:59 UTC -4
Closed
After-Market
16.65
-0.01
-0.06%
Janux Therapeutics, Inc. Common Stock (JANX) Earnings
JANX Earnings Reports
Positive Surprise Ratio
JANX beat 15 of 21 last estimates.
71%
Next Report
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$7.90M
/-$0.48
Implied change from Q2 26 (Revenue/ EPS)
-23.05%
/+37.14%
Implied change from Q3 25 (Revenue/ EPS)
-20.99%
/+23.08%
Janux Therapeutics, Inc. Common Stock earnings per share and revenue
On Aug 06, 2026, JANX reported earnings of -0.35 USD per share (EPS) for Q2 26, beating the estimate of -0.39 USD, resulting in a 10.71% surprise. Revenue reached 10.27 million, compared to an expected 16.82 million, with a -38.97% difference. The market reacted with a -1.55% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 15 analysts forecast an EPS of -0.48 USD, with revenue projected to reach 7.90 million USD, implying an increase of 37.14% EPS, and decrease of -23.05% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tiziana Life Sciences Ltd. Common Shares
Report Date
Oct 16, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.10
Surprise
-22.55%
argenx SE - ADR
Report Date
Oct 22, 2026 For Q3 26
Estimate
$8.19
Actual
$7.80
Surprise
-4.84%
QIAGEN N.V.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.63
Actual
$0.65
Surprise
+2.43%
Nurix Therapeutics, Inc. Common stock
Report Date
Oct 12, 2026 For Q3 26
Estimate
-$0.61
Actual
$4.73
Surprise
+871.74%
FAQ
What were Janux Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Janux Therapeutics, Inc. Common Stock reported EPS of -$0.35, beating estimates by 10.71%, and revenue of $10.27M, -38.97% below expectations.
How did the market react to Janux Therapeutics, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -1.55%, changed from $16.10 before the earnings release to $15.85 the day after.
When is Janux Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Janux Therapeutics, Inc. Common Stock's next earnings report?
Based on 15
analysts, Janux Therapeutics, Inc. Common Stock is expected to report EPS of -$0.48 and revenue of $7.90M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.